Reportlinker Adds Genetic Testing Reagents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

NEW YORK, April 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Genetic Testing Reagents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

http://www.reportlinker.com/p0479886/Genetic-Testing-Reagents---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html

Genetic Testing Reagents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData's new report, "Genetic Testing Reagents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global genetic testing market. The report provides market landscape, competitive landscape and market trends information on the genetic testing market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Key segments covered include Inborn Gene or Chromosome Alterations, Acquired Gene or Chromosome Alterations, and Other Genetic Tests.

- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.

- Qualitative analysis of key market trends, market drivers, and restraints by each category within genetic testing market.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Key players covered include Qiagen, F. Hoffmann-La Roche, Abbott Laboratories, Hologic, Siemens Healthcare, and Biomerieux Sa.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the genetic testing market globally.

- Design and develop your product development, marketing and sales strategies.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What's the next big thing in the genetic testing market landscape? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global genetic testing market and the factors shaping it.

1 Table of contents

1 Table of contents 3

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 GlobalData Report Guidance 7

3 Genetic Testing Overview 8

3.1 Introduction 8

3.2 Major Diseases Diagnosed Using Genetic Testing 8

3.2.1 Hemophilia 8

3.2.2 Thalassemia 8

3.2.3 Sickle-cell Anemia 9

3.2.4 Cystic Fibrosis 9

3.2.5 Tay – Sachs Disease 9

3.2.6 Down Syndrome 9

3.2.7 Huntington's Disease 10

3.2.8 Mutations in Oncogenes 10

4 Genetic Testing: Market Characterization 11

4.1 Genetic Testing Market, Global, Revenue ($m), Historic, 2003-2010 11

4.2 Genetic Testing Market, Global, Revenue ($m), Forecast, 2010-2017 12

4.3 Genetic Testing Market, Key Trends 13

4.3.1 Increase in the Number of Genetic Tests Available for Diagnosis of Medical Conditions 13

4.3.2 Increased Awareness of Pre-natal and Pre-symptomatic Genetic Tests will Increase the Number of Individuals Undertaking Genetic Tests 14

4.4 Genetic Testing, Market Dynamics 15

4.4.1 Market Drivers 16

4.4.2 Market Restraints 17

5 Genetic Testing Market: Segment Analysis 18

5.1 Inborn Gene or Chromosome Alterations 18

5.2 Inborn Gene or Chromosome Alterations Market, Global, Revenue ($m), Historic, 2003-2010 19

5.3 Inborn Gene or Chromosome Alterations Market, Global, Revenue ($m), Forecast, 2010-2017 20

5.4 Inborn Gene or Chromosome Alterations, Market Dynamics 21

5.4.1 Market Driver: Increasing Awareness about the Role of Genomics in Susceptibility to Diseases has led to a Growth in Pre-natal testing 21

5.4.2 Market Restraint: Invasive Procedures for Prenatal Testing Increase the Risk of Miscarriages 21

5.5 Acquired Gene or Chromosome Alterations 22

5.6 Acquired Gene or Chromosome Alterations, Global, Revenue ($m), Historic, 2003-2010 22

5.7 Acquired Gene or Chromosome Alterations, Global, Revenue ($m), Forecast, 2010-2017 23

5.8 Acquired Gene or Chromosome Alterations, Market Dynamics 24

5.8.1 Market Driver: The Need for Early Diagnosis of Cancer and the Increasing Number of Cancer Patients is Boosting Genetic Testing 24

5.8.2 Market Restraint: High Costs Involved in Screening Procedures is Preventing Patients from Undertaking the Tests 24

5.9 Other Genetic Tests 24

5.10 Other Genetic Tests, Global, Revenue ($m), Historic, 2003-2010 25

5.11 Other Genetic Tests, Global, Revenue ($m), Forecast, 2010-2017 26

5.12 Other Genetic Tests, Market Dynamics 27

5.12.1 Market Driver: Shifting Focus on Personalized Medicine by Pharmaceutical Companies will lead to an Increase in the number of Genetic Tests 27

6 Genetic Testing Market, by Country, Revenue ($m), 2003 – 2017 28

6.1 Genetic Testing Market, the US, Revenue ($m), Historic, 2003 – 2010 28

6.2 Genetic Testing Market, the US, Revenue ($m), Forecast, 2010 – 2017 29

6.3 Genetic Testing Market, Canada, Revenue ($m), Historic, 2003 – 2010 30

6.4 Genetic Testing Market, Canada, Revenue ($m), Forecast, 2010 – 2017 31

6.5 Genetic Testing Market, the UK, Revenue ($'000), Historic, 2003 – 2010 32

6.6 Genetic Testing Market, the UK, Revenue ($'000), Forecast, 2010 – 2017 33

6.7 Genetic Testing Market, Germany, Revenue ($'000), Historic, 2003 – 2010 34

6.8 Genetic Testing Market, Germany, Revenue ($'000), Forecast, 2010 – 2017 35

6.9 Genetic Testing Market, France, Revenue ($'000), Historic, 2003 – 2010 36

6.10 Genetic Testing Market, France, Revenue ($'000), Forecast, 2010 – 2017 37

6.11 Genetic Testing Market, Italy, Revenue ($'000), Historic, 2003 – 2010 38

6.12 Genetic Testing Market, Italy, Revenue ($'000), Forecast, 2010 – 2017 39

6.13 Genetic Testing Market, Spain, Revenue ($'000), Historic, 2003 – 2010 40

6.14 Genetic Testing Market, Spain, Revenue ($'000), Forecast, 2010 – 2017 41

6.15 Genetic Testing Market, Japan, Revenue ($'000), Historic, 2003 – 2010 42

6.16 Genetic Testing Market, Japan, Revenue ($'000), Forecast, 2010 – 2017 43

6.17 Genetic Testing Market, China, Revenue ($'000), Historic, 2003 – 2010 44

6.18 Genetic Testing Market, China, Revenue ($'000), Forecast, 2010 – 2017 45

6.19 Genetic Testing Market, India, Revenue ($'000), Historic, 2003 – 2010 46

6.20 Genetic Testing Market, India, Revenue ($'000), Forecast, 2010 – 2017 47

6.21 Genetic Testing Market, Australia, Revenue ($'000), Historic, 2003 – 2010 48

6.22 Genetic Testing Market, Australia, Revenue ($'000), Forecast, 2010 – 2017 49

6.23 Genetic Testing Market, Brazil, Revenue ($'000), Historic, 2003 – 2010 50

6.24 Genetic Testing Market, Brazil, Revenue ($'000), Forecast, 2010 – 2017 51

7 Genetic Testing Market: Strategic Competitive Assessment 52

7.1 Genetic Testing Market, Key Market Participants 53

7.1.1 Qiagen N. V. 53

7.1.2 F. Hoffmann-La Roche Ltd. 56

7.1.3 Abbott Laboratories 59

7.1.4 Hologic Inc. 61

8 Genetic Testing Market: Strategic Pipeline Assessment 65

8.1 Pipeline Products Summary 65

8.2 Profiles of Promising Products Under Clinical Development 66

8.2.1 Verigene CYP2C19 Assay 66

8.2.2 KIF6 Test-Coronary Heart Disease 67

8.2.3 Biomarker for Breast Cancer Genetic Risk Assessment 69

8.2.4 AmoyDx Mutation Detection Kit 70

9 Genetic Testing Market: M&A Landscape 71

9.1 Genetic Testing Market: Deals Overview 71

9.2 Key Acquisitions 72

9.2.1 Danaher Acquires Beckman Coulter 72

9.2.2 Invitrogen Merges with Applied Biosystems to form Life Technologies 72

9.2.3 Qiagen Acquires Digene 73

9.2.4 LabCorp Completes Acquisition of Genzyme Genetics From Genzyme 73

9.2.5 Hologic Acquires Third Wave Technologies 73

10 Appendix 74

10.1 Definitions 74

10.1.1 Deoxyribonucleic Acid: 74

10.1.2 Ribonucleic Acid: 74

10.1.3 Chromosome: 74

10.1.4 Phenylketonuria: 74

10.1.5 Polymerase Chain Reaction: 74

10.1.6 Joint Venture 74

10.2 Acronyms 75

10.3 Research Methodology 76

10.4 Secondary Research 76

10.5 Primary Research 77

10.6 Models 77

10.7 Forecasts 77

10.8 Expert Panels 78

10.9 GlobalData Consulting 78

10.10 Contact Us 78

10.11 Disclaimer 78

1.1 List of Tables

Table 1: Genetic Testing Market, Global, Revenue ($m), 2003-2010 11

Table 2: Genetic Testing Market, Global, Revenue ($m), 2010-2017 12

Table 3: Inborn Gene or Chromosome Alterations Market, Global, Revenue ($m), 2003-2010 19

Table 4: Inborn Gene or Chromosome Alterations Market, Global, Revenue ($m), 2010-2017 20

Table 5: Acquired Gene or Chromosome Alterations, Global, Revenue ($m), 2003-2010 22

Table 6: Acquired Gene or Chromosome Alterations, Global, Revenue ($m), 2010-2017 23

Table 7: Other Genetic Tests, Global, Revenue ($m), 2003-2010 25

Table 8: Other Genetic Tests, Global, Revenue ($m), 2010-2017 26

Table 9: List of Drugs Affected due to Genetic Variation Among Patients 27

Table 10: Genetic Testing Market, the US, Revenue ($m), 2003 – 2010 28

Table 11: Genetic Testing Market, the US, Revenue ($m), 2010 – 2017 29

Table 12: Genetic Testing Market, Canada, Revenue ($m), 2003 – 2010 30

Table 13: Genetic Testing Market, Canada, Revenue ($m), 2010 – 2017 31

Table 14: Genetic Testing Market, the UK, Revenue ($'000), 2003 – 2010 32

Table 15: Genetic Testing Market, the UK, Revenue ($'000), 2010 – 2017 33

Table 16: Genetic Testing Market, Germany, Revenue ($'000), 2003 – 2010 34

Table 17: Genetic Testing Market, Germany, Revenue ($'000), 2010 – 2017 35

Table 18: Genetic Testing Market, France, Revenue ($'000), 2003 – 2010 36

Table 19: Genetic Testing Market, France, Revenue ($'000), 2010 – 2017 37

Table 20: Genetic Testing Market, Italy, Revenue ($'000), 2003 – 2010 38

Table 21: Genetic Testing Market, Italy, Revenue ($'000), 2010 – 2017 39

Table 22: Genetic Testing Market, Spain, Revenue ($'000), 2003 – 2010 40

Table 23: Genetic Testing Market, Spain, Revenue ($'000), 2010 – 2017 41

Table 24: Genetic Testing Market, Japan, Revenue ($'000), 2003 – 2010 42

Table 25: Genetic Testing Market, Japan, Revenue ($'000), 2010 – 2017 43

Table 26: Genetic Testing Market, China, Revenue ($'000), 2003 – 2010 44

Table 27: Genetic Testing Market, China, Revenue ($'000), 2010 – 2017 45

Table 28: Genetic Testing Market, India, Revenue ($'000), 2003 – 2010 46

Table 29: Genetic Testing Market, India, Revenue ($'000), 2010 – 2017 47

Table 30: Genetic Testing Market, Australia, Revenue ($'000), 2003 – 2010 48

Table 31: Genetic Testing Market, Australia, Revenue ($'000), 2010 – 2017 49

Table 32: Genetic Testing Market, Brazil, Revenue ($'000), 2003 – 2010 50

Table 33: Genetic Testing Market, Brazil, Revenue ($'000), 2010 – 2017 51

Table 34: Genetic Testing Market, Global, Company Revenue ($m), 2009 52

Table 35: Qiagen N. V. Marketed Products 53

Table 36: Qiagen N. V. Pipeline Products 53

Table 37: F. Hoffmann-La Roche Marketed Products 56

Table 38: Major Product Launches, F. Hoffmann-La Roche, 2011 57

Table 39: Key Product Launches, F. Hoffmann-La Roche, 2011 57

Table 40: Abbott Laboratories Marketed Products 60

Table 41: Hologic Inc. Marketed Products 62

Table 42: Hologic Inc. Pipeline Products 62

Table 43: Verigene CYP2C19 Assay, Product Description 66

Table 44: Verigene CYP2C19 Assay, Product Status 66

Table 45: KIF6 Test-Coronary Heart Disease, Product Description 67

Table 46: KIF6 Test-Coronary Heart Disease, Product Status 67

Table 47: KIF6 Test-Coronary Heart Disease, Clinical Trial 68

Table 48: Biomarker for Breast Cancer Genetic Risk Assessment, Product Description 69

Table 49: Biomarker for Breast Cancer Genetic Risk Assessment, Product Status 69

Table 50: AmoyDx Mutation Detection Kit, Product Description 70

Table 51: AmoyDx Mutation Detection Kit, Product Status 70

Table 52: Genetic Testing Market, Global, Number of Deals and Deal Value ($m), 2004-2010 71

1.2 List of Figures

Figure 1: Genetic Testing Market, Global, Revenue ($m), 2003-2010 11

Figure 2: Genetic Testing Market, Global, Revenue ($m), 2010-2017 12

Figure 3: Availability of Genetic Tests, Global, 1993-2010 13

Figure 4: Genetic Testing, Market Dynamics 15

Figure 5: Inborn Gene or Chromosome Alterations Market, Global, Revenue ($m), 2003-2010 19

Figure 6: Inborn Gene or Chromosome Alterations Market, Global, Revenue ($m), 2010-2017 20

Figure 7: Acquired Gene or Chromosome Alterations, Global, Revenue ($m), 2003-2010 22

Figure 8: Acquired Gene or Chromosome Alterations, Global, Revenue ($m), 2010-2017 23

Figure 9: Other Genetic Tests, Global, Revenue ($m), 2003-2010 25

Figure 10: Other Genetic Tests, Global, Revenue ($m), 2010-2017 26

Figure 11: Genetic Testing Market, the US, Revenue ($m), 2003 – 2010 28

Figure 12: Genetic Testing Market, the US, Revenue ($m), 2010 – 2017 29

Figure 13: Genetic Testing Market, Canada, Revenue ($m), 2003 – 2010 30

Figure 14: Genetic Testing Market, Canada, Revenue ($m), 2010 – 2017 31

Figure 15: Genetic Testing Market, the UK, Revenue ($'000), 2003 – 2010 32

Figure 16: Genetic Testing Market, the UK, Revenue ($'000), 2010 – 2017 33

Figure 17: Genetic Testing Market, Germany, Revenue ($'000), 2003 – 2010 34

Figure 18: Genetic Testing Market, Germany, Revenue ($'000), 2010 – 2017 35

Figure 19: Genetic Testing Market, France, Revenue ($'000), 2003 – 2010 36

Figure 20: Genetic Testing Market, France, Revenue ($'000), 2010 – 2017 37

Figure 21: Genetic Testing Market, Italy, Revenue ($'000), 2003 – 2010 38

Figure 22: Genetic Testing Market, Italy, Revenue ($'000), 2010 – 2017 39

Figure 23: Genetic Testing Market, Spain, Revenue ($'000), 2003 – 2010 40

Figure 24: Genetic Testing Market, Spain. Revenue ($'000), 2010 – 2017 41

Figure 25: Genetic Testing Market, Japan, Revenue ($'000), 2003 – 2010 42

Figure 26: Genetic Testing Market, Japan, Revenue ($'000), 2010 – 2017 43

Figure 27: Genetic Testing Market, China, Revenue ($'000), 2003 – 2010 44

Figure 28: Genetic Testing Market, China, Revenue ($'000), 2010 – 2017 45

Figure 29: Genetic Testing Market, India, Revenue ($'000), 2003 – 2010 46

Figure 30: Genetic Testing Market, India, Revenue ($'000), 2010 – 2017 47

Figure 31: Genetic Testing Market, Australia, Revenue ($'000), 2003 – 2010 48

Figure 32: Genetic Testing Market, Australia, Revenue ($'000), 2010 – 2017 49

Figure 33: Genetic Testing Market, Brazil, Revenue ($'000), 2003 – 2010 50

Figure 34: Genetic Testing Market, Brazil, Revenue ($'000), 2010 – 2017 51

Figure 35: Genetic Testing Market, Global, Company Share (%), 2009 52

Figure 36: Qiagen N. V. Deals Landscape 54

Figure 37: Qiagen N.V. SWOT Analysis 54

Figure 38: F. Hoffmann-La Roche Deals Landscape 56

Figure 39: F. Hoffmann-La Roche SWOT Analysis 58

Figure 40: Abbott Laboratories Deals Landscape 59

Figure 41: Abbott Laboratories SWOT Analysis 60

Figure 42: Hologic Inc. Deals Landscape 61

Figure 43: Hologic Inc. SWOT Analysis 62

Figure 44: Pipeline Products, by Segment, 2010 65

Figure 45: Genetic Testing Market, Global, Number of Deals and Deal Value ($m), 2004-2010 71Qiagen N. V.

F. Hoffmann-La Roche Ltd.

Abbott Laboratories

Hologic Inc.

To order this report:

: Genetic Testing Reagents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker